23,182,000 Shares CASCADIAN THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • January 24th, 2017 • Cascadian Therapeutics, Inc. • Services-commercial physical & biological research • New York
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 24th, 2017 • Cascadian Therapeutics, Inc. • Services-commercial physical & biological research • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of January , 2017, by and among Cascadian Therapeutics, Inc., a Delaware corporation (the “Company”), and the several purchasers signatory hereto (each a “Purchaser” and collectively, the “Purchasers”).
1,818 Shares CASCADIAN THERAPEUTICS, INC. Series E Convertible Preferred Stock UNDERWRITING AGREEMENTUnderwriting Agreement • January 24th, 2017 • Cascadian Therapeutics, Inc. • Services-commercial physical & biological research • New York
